Live modified horsepox virus vaccine (Tonix Pharmaceuticals)

N/A

Report date: 2024/04/09 11:55:19

Base Information

Drug NameLive modified horsepox virus vaccine (Tonix Pharmaceuticals)

Drug Alias NameTNX-1800

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTonix Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A